Atlas Trials

A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)

Clinical trial NCT05262881 · UNKNOWN

Trial details

NCT number
NCT05262881
Sponsor
Catholic University of the Sacred Heart
Status
UNKNOWN
Study type
OBSERVATIONAL
Thrombotic Thrombocytopenic Purpura, Acquired
Start date
2022-03-01
Primary completion
2022-09-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.